Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06406647 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Rectroclavicular Block in Orthopedic Surgey

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jan 1, 2025 to Dec 1, 2026
    • Start date: Jun 1, 2024 to Apr 1, 2026
    • Study completion date: Feb 1, 2025 to Dec 1, 2026
    v4
  2. Trial status: Not Yet Recruiting to Recruitingv3
  3. Primary endpoint revised
    • Eligibility criteria shortened, about 13 words
    • Study description shortened, about 130 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The ultrasound-guided retroclavicular approach to the infraclavicular region (RAPTIR) brachial plexus block has gained popularity as a relatively easy-to-perform nerve block that provides reliable and dense anesthesia to the upper extremity with a single injection. The block has been well described in the anesthesia community since it was first introduced by Hebbard and Royse in 2007 . In 2017, Luftig first described the block's use in the ED setting for a variety of indications . This nerve block has classically been described to provide extensive anesthesia for procedures distal to the shoulder, such as elbow dislocations, distal radius fractures, and surgical procedures.
Trial Details
NCT Number NCT06406647
Lead Sponsor New Valley University
Conditions
(from sponsor)		 Pain Management
Related terms Agnosia
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov